期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
细胞凋亡和继发性坏死的Annexin法定量检测 被引量:7
1
作者 彭黎明 江虹 ChrisBradley 《华西医科大学学报》 CAS CSCD 北大核心 2001年第4期602-604,620,共4页
目的 探讨分析凋亡与坏死淋巴瘤 (Raji)细胞的定量方法。方法 以 1.0 μm ol/ L 地塞米松(DEX)诱导 Raji细胞凋亡 ,用异硫氰酸荧光素标记的连接素 V(Annexin V)和碘化丙锭 (PI)分别与凋亡细胞膜上的磷脂酰丝氨酸和继发性坏死细胞内降... 目的 探讨分析凋亡与坏死淋巴瘤 (Raji)细胞的定量方法。方法 以 1.0 μm ol/ L 地塞米松(DEX)诱导 Raji细胞凋亡 ,用异硫氰酸荧光素标记的连接素 V(Annexin V)和碘化丙锭 (PI)分别与凋亡细胞膜上的磷脂酰丝氨酸和继发性坏死细胞内降解的 DNA结合 ,并以流式细胞术分析和分选标记细胞 ,用电镜和 DNA凝胶电泳对分选细胞及其 DNA进行鉴定。结果  Annexin+细胞数随 DEX孵育时间的延长而增加 (r=0 .97) ;Annexin+/ PI- 与 Annexin+/ PI+细胞经电镜和 DNA梯形带确证具有凋亡与坏死细胞的特征 ;Annexin法可准确测定 10 5~ 10 6细胞中的标记细胞。结论  Annexin法可快速。 展开更多
关键词 连接素V 流式细胞术 细胞凋亡 细胞坏死 annexin法 定量检测
下载PDF
用Annexin法定量分析淋巴瘤细胞凋亡与坏死 被引量:13
2
作者 彭黎明 《中华医学检验杂志》 CSCD 1999年第1期49-49,共1页
目前,检测细胞凋亡的方法逐渐增多和完善。现介绍一种Annexin法:基于早期凋亡细胞因细胞膜的磷脂对称性改变而使磷脂酰丝氨酸(PS)暴露于细胞膜外,PS可特异结合标记有异硫氰酸荧光素(FITC)的连接素V(Annex... 目前,检测细胞凋亡的方法逐渐增多和完善。现介绍一种Annexin法:基于早期凋亡细胞因细胞膜的磷脂对称性改变而使磷脂酰丝氨酸(PS)暴露于细胞膜外,PS可特异结合标记有异硫氰酸荧光素(FITC)的连接素V(AnnexinV),但细胞仍维持其细胞膜的完... 展开更多
关键词 淋巴瘤 细胞凋亡 annexin法 定量分析
原文传递
Annexin V/PI法流式细胞术检测细胞凋亡的影响因素 被引量:2
3
作者 管强东 杨健 +3 位作者 刘艳青 熊建平 钟义红 沈链链 《生物技术》 CAS 2022年第6期710-714,共5页
[目的]探讨消化液、细胞数量及试剂温度对Annexin V/PI法流式细胞术检测细胞凋亡率的影响。[方法]细胞经Accutase或无EDTA胰酶消化后比较检测结果;含有0.5×10^(5)、1×10^(5)、2×10^(5)细胞的样本按照说明书推荐(默认含有... [目的]探讨消化液、细胞数量及试剂温度对Annexin V/PI法流式细胞术检测细胞凋亡率的影响。[方法]细胞经Accutase或无EDTA胰酶消化后比较检测结果;含有0.5×10^(5)、1×10^(5)、2×10^(5)细胞的样本按照说明书推荐(默认含有1×10^(5)细胞)加入试剂后,比较检测结果;细胞加入室温或4℃试剂后比较检测结果。以上比较均用未处理细胞和秋水仙素处理细胞分别进行。[结果]对于未处理细胞而言,与无EDTA胰酶相比,Accutase能显著减少凋亡率(2.70%vs 18.05%);而经药物处理的细胞,Accutase组凋亡率也有一定程度减少(22.32%vs 26.50%),但差异没有未处理细胞大。未处理细胞随着细胞数量的增加,PI信号并未发生明显改变,Annexin V-FITC信号与细胞数量成反比,统一十字门分析的凋亡率分别是:2.46%、1.85%、1.35%。对于药物处理的细胞差异尤其明显,统一十字门分析的凋亡率分别是:28.83%、21.27%、15.59%,因此不能用统一的十字门分析。加入4℃试剂的未处理细胞的凋亡率明显高于加入室温试剂的细胞的凋亡率(3.77%vs 8.13%),而对于药物处理的细胞,两者基本无差别(22.94%vs 22.18%)。[结论]用Annexin V/PI法流式细胞术检测细胞凋亡率时,使用Accutase消化液;样本严格计数,使细胞数符合说明书要求;使用室温试剂。 展开更多
关键词 流式细胞术 annexin V/PI 细胞调亡 影响因素
原文传递
Dynamic changes and surveillance function of prion protein expression in gastric cancer drug resistance 被引量:9
4
作者 Ji-Heng Wang Jing-Ping Du +5 位作者 Ying-Hai Zhang Xiao-Jun Zhao Ru-Ying Fan Zhi-Hong Wang Zi-Tao Wu Ying Han 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第35期3986-3993,共8页
AIM:To explore the dynamic changes of prion protein (PrPc) in the process of gastric cancer drug resistance and the role of PrPc expression in the prognosis of gastric cancer patients receiving chemotherapy.METHODS:A ... AIM:To explore the dynamic changes of prion protein (PrPc) in the process of gastric cancer drug resistance and the role of PrPc expression in the prognosis of gastric cancer patients receiving chemotherapy.METHODS:A series of gastric cancer cell lines resistant to different concentrations of adriamycin was established,and the expression of PrPc,Bcl-2 and Bax was detected in these cells.Apoptosis was determined using Annexin V staining.Western blotting and immunohisto-chemistry were performed to detect the expression of PrPc in patients receiving chemotherapy and to explore the role of PrPc expression in predicting the chemosensitivity and the outcome of gastric cancer patients receiving chemotherapy.Follow-up was performed for 2 years.RESULTS:PrPc expression was increased with the increase in drug resistance.Bcl-2,together with PrPc,increased the level of anti-apoptosis of cancer cells.Increased PrPc expression predicted the enhanced level of anti-apoptosis and resistance to anticancer drugs.PrPc expression could be used as a marker for predicting the efficacy of chemotherapy and the prognosis of gastric cancer.Increased PrPc expression predicted both poor chemosensitivity and a low 2-year survival rate.Contrarily,low PrPc expression predicted favorable chemosensitivity and a relatively high 2-year survival rate.CONCLUSION:PrPc expression is associated with histological types and differentiation of gastric cancer cells;The PrPc expression level might be a valuable marker in predicting the efficacy of chemotherapy and the prognosis of gastric cancer patients receiving chemotherapy. 展开更多
关键词 Prion protein Gastric cancer Drug resistance CHEMOTHERAPY APOPTOSIS
下载PDF
MicroRNA-15a/b are up-regulated in response to myocardial ischemia/reperfusion injury 被引量:15
5
作者 Li-Feng Liu Zhuo Liang +5 位作者 Zhen-Rong Lv Xiu-Hua Liu Jing Bai Jie Chen Chen Chen Yu Wang 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2012年第1期28-32,共5页
Objective Several studies have indicated that miR-15a,miR-15b and miR-16 may be the important regulators of apoptosis.Since attenuate apoptosis could protect myocardium and reduce infarction size,the present study was... Objective Several studies have indicated that miR-15a,miR-15b and miR-16 may be the important regulators of apoptosis.Since attenuate apoptosis could protect myocardium and reduce infarction size,the present study was aimed to find out whether these miRNAs participate in regulating myocardial ischemia reperfusion (I/R) injury.Methods Apoptosis in mice hearts subjected to I/R was detected by TUNEL assay in vivo,while flow cytometry analysis followed by Annexin V/PI double stain in vitro was used to detect apoptosis in cultured cardiomyocytes which were subjected to hypoxia/reoxygenation (H/R).Taqman real-time quantitative PCR was used to confirm whether miR-15a/15b/16 were involved in the regulation of cardiac I/R and H/R.Results Compared to those of the controls,I/R or H/R induced apoptosis of cardiomyocytes was significantly iucreased both in vivo (24.4% ± 9.4% vs.2.2% ± 1.9%,P < 0.01,n =5) and in vitro (14.12% ±0.92% vs.2.22% ± 0.08%).The expression of miR-15a and miR-15b,but not miR-16,was increased in the mice I/R model,and the results were consistent in the H/R model.Conclusions Our data indicate miR-15 and miR-15b are up-regulated in response to cardiac I/R injury,therefore,down-regulation of miR- 15a/b may be a promising strategy to reduce myocardial apoptosis induced by cardiac I/R injury. 展开更多
关键词 miR-15a/b APOPTOSIS Myocardial reperfusion injury Ischemia/Reperfusion injury
下载PDF
盐酸小檗碱/叶酸-壳聚糖纳米粒的制备及其对CNE-1细胞的抑制作用 被引量:4
6
作者 温宝芳 李文涛 +2 位作者 庄宝祥 张维芬 赵立民 《中草药》 CAS CSCD 北大核心 2016年第20期3594-3601,共8页
目的制备载盐酸小檗碱(berberine hydrochloride,BH)的叶酸(folic acid,FA)偶联壳聚糖(chitosan,CTS)纳米粒(BH/FA-CTS-NPs),优化制备工艺并考察BH/FA-CTS-NPs的理化特性及其对CNE-1细胞的抑制作用。方法利用FA活性酯与CTS分子上的氨基... 目的制备载盐酸小檗碱(berberine hydrochloride,BH)的叶酸(folic acid,FA)偶联壳聚糖(chitosan,CTS)纳米粒(BH/FA-CTS-NPs),优化制备工艺并考察BH/FA-CTS-NPs的理化特性及其对CNE-1细胞的抑制作用。方法利用FA活性酯与CTS分子上的氨基反应,制得FA偶联CTS(FA-CTS);BH为模型药物,通过离子交联法制备BH/FA-CTS-NPs。考察其形态、粒径、包封率、载药量及体外释放等理化特性;分别通过MTT法、划痕实验和Annexin-V-FITC单染法进行检测,验证BH/FA-CTS-NPs对CNE-1细胞的抑制作用、抗增殖侵袭能力以及诱导凋亡作用。结果透射电镜下观察所得BH/FA-CTS-NPs形态外观圆整,大小均匀,无粘连,平均粒径为(282.4±4.5)nm;包封率为(89.82±2.91)%;载药量为(9.16±1.01)%;5 h内累积释药率为(80.32±3.24)%,随后缓慢释放,24 h内累积释药率为(90.92±5.21)%。CNE-1细胞实验显示,BH/FA-CTS-NPs能够显著抑制CNE-1细胞的生存和增殖能力,诱导细胞CNE-1凋亡,具有剂量和时间依赖性。结论离子交联法成功制备具有体外缓释作用的BH/FA-CTS-NPs,形态圆整,粒径大小均一,对抑制CNE-1细胞增殖及促进凋亡效果好,为开发抗肿瘤给药系统提供了理论依据。 展开更多
关键词 叶酸 壳聚糖 盐酸小檗碱 纳米粒 偶联 离子交联 MTT 划痕实验 annexin—V-FITC单染 抗肿瘤 抗增殖侵袭能力:凋亡
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部